Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Reply to Praprotnik and Tomsic and erratum corrige.

Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Iannone F.

Clin Exp Rheumatol. 2020 Mar 11. [Epub ahead of print] No abstract available.

PMID:
32167876
2.

Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome.

Silvestri E, Bitossi A, Bettiol A, Emmi G, Urban ML, Mattioli I, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Prisco D.

Inflammopharmacology. 2020 Mar 10. doi: 10.1007/s10787-020-00697-4. [Epub ahead of print]

PMID:
32157555
3.

Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes.

Vitale A, Cavalli G, Ruscitti P, Sota J, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cavallaro E, Massaro MG, Cipriani P, De Marchi G, De Vita S, Emmi G, Frassi M, Gerli R, Gremese E, Iannone F, Fornaro M, Paladini A, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Frediani B, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Grosso S, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Med (Lausanne). 2020 Feb 21;7:42. doi: 10.3389/fmed.2020.00042. eCollection 2020.

4.

Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.

Gaggiano C, Rigante D, Vitale A, Lucherini OM, Fabbiani A, Capozio G, Marzo C, Gelardi V, Grosso S, Frediani B, Renieri A, Cantarini L.

Mediators Inflamm. 2019 Dec 31;2019:3293145. doi: 10.1155/2019/3293145. eCollection 2019. Review.

5.

Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study.

Frediani B, Toscano C, Falsetti P, Nicosia A, Pierguidi S, Migliore A, Giannotti S, Cantarini L, Conticini E.

Drugs R D. 2020 Mar;20(1):39-45. doi: 10.1007/s40268-020-00294-4.

6.

Response to: 'Do we need the PFAPA syndrome in adults with non-monogenic periodic fevers?' by Fayand et al.

Gattorno M, Hofer M, Vanoni F, Federici S, Cantarini L, Ruperto N.

Ann Rheum Dis. 2020 Feb 7. pii: annrheumdis-2019-216862. doi: 10.1136/annrheumdis-2019-216862. [Epub ahead of print] No abstract available.

PMID:
32033939
7.

Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.

Sota J, Rigante D, Emmi G, Lopalco G, Orlando I, Tosi GM, Frediani B, Vitale A, Guerriero S, Iannone F, Vannozzi L, Fabiani C, Cantarini L.

Intern Emerg Med. 2020 Feb 1. doi: 10.1007/s11739-019-02248-4. [Epub ahead of print]

PMID:
32006221
8.

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study.

D'Angelo S, Cantini F, Ramonda R, Cantarini L, Carletto A, Chimenti MS, Delle Sedie A, Foti R, Gerli R, Lomater C, Lubrano E, Marchesoni A, Zabotti A, Salvarani C, Scrivo R, Scarpa R, Tramontano G, Nannini C, Lorenzin M, Fabbroni M, Martinis F, Perricone R, Carli L, Visalli E, Rovera G, Perrotta FM, Quartuccio L, Altobelli A, Costa L, Niccoli L, Ortolan A, Caso F.

Front Pharmacol. 2019 Dec 13;10:1497. doi: 10.3389/fphar.2019.01497. eCollection 2019.

9.

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors.

Fabiani C, Vitale A, Emmi G, Sgheri A, Lopalco G, Sota J, Guerriero S, Iannone F, Frediani B, Vannozzi L, Bianco MT, Giovannini V, Tosi GM, Cantarini L.

Front Pharmacol. 2019 Dec 9;10:1468. doi: 10.3389/fphar.2019.01468. eCollection 2019.

10.

Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Colafrancesco S, Manara M, Bortoluzzi A, Serban T, Bianchi G, Cantarini L, Ciccia F, Dagna L, Govoni M, Montecucco C, Priori R, Ravelli A, Sfriso P, Sinigaglia L; AOSD Consensus Group.

Arthritis Res Ther. 2020 Jan 9;22(1):6. doi: 10.1186/s13075-019-2094-5.

11.

Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.

Conticini E, Selvi E, Cantarini L, Frediani B.

Rheumatology (Oxford). 2019 Dec 16. pii: kez608. doi: 10.1093/rheumatology/kez608. [Epub ahead of print] No abstract available.

PMID:
31840175
12.

Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Colafrancesco S, Manara M, Bortoluzzi A, Serban T, Bianchi G, Cantarini L, Ciccia F, Dagna L, Govoni M, Montecucco C, Priori R, Ravelli A, Sfriso P, Sinigaglia L; AOSD Consensus Group.

Arthritis Res Ther. 2019 Dec 11;21(1):275. doi: 10.1186/s13075-019-2021-9. Erratum in: Arthritis Res Ther. 2020 Jan 9;22(1):6.

13.

Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.

Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L.

Clin Rheumatol. 2020 Feb;39(2):327-337. doi: 10.1007/s10067-019-04763-3. Epub 2019 Dec 10.

PMID:
31823144
14.

Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.

Tosi GM, Vitale A, Rigante D, Sota J, Emmi G, Lopalco G, Guerriero S, Iannone F, Vannozzi L, Bitossi A, Frediani B, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Oct 17. [Epub ahead of print]

PMID:
31694738
15.

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.

Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL, Brucato A, Adler Y.

Eur J Prev Cardiol. 2019 Oct 15:2047487319879534. doi: 10.1177/2047487319879534. [Epub ahead of print]

PMID:
31610707
16.

Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis.

De Andrea M, De Santis M, Caneparo V, Generali E, Sirotti S, Isailovic N, Guidelli GM, Ceribelli A, Fabbroni M, Simpatico A, Cantarini L, Gisondi P, Idolazzi L, Gariglio M, Selmi C.

Clin Exp Immunol. 2020 Jan;199(1):88-96. doi: 10.1111/cei.13376. Epub 2019 Oct 15.

PMID:
31571199
17.

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.

Ruscitti P, Masedu F, Alvaro S, Airò P, Battafarano N, Cantarini L, Cantatore FP, Carlino G, D'Abrosca V, Frassi M, Frediani B, Iacono D, Liakouli V, Maggio R, Mulè R, Pantano I, Prevete I, Sinigaglia L, Valenti M, Viapiana O, Cipriani P, Giacomelli R.

PLoS Med. 2019 Sep 12;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. eCollection 2019 Sep.

18.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

19.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
20.

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases.

Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, Modesto C, Hofer M, Iagaru N, Fingerhutová S, Insalaco A, Licciardi F, Uziel Y, Jelusic M, Nikishina I, Nielsen S, Papadopoulou-Alataki E, Olivieri AN, Cimaz R, Susic G, Stanevica V, van Gijn M, Vitale A, Ruperto N, Frenkel J, Gattorno M; Eurofever registry and the Pediatric Rheumatology International Trial Organization (PRINTO).

Ann Rheum Dis. 2019 Oct;78(10):1405-1411. doi: 10.1136/annrheumdis-2018-214472. Epub 2019 Jul 5.

PMID:
31278138
21.

Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Lucherini OM, Vitale A, Obici L, Sota J, Frediani B, Merlini G, Rigante D, Cantarini L.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):159-160. Epub 2019 May 30. No abstract available.

22.

Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.

Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.

PMID:
31025925
23.

Classification criteria for autoinflammatory recurrent fevers.

Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. Review.

PMID:
31018962
24.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

25.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

26.

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):680-683. Epub 2019 Apr 3.

27.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

28.

Magnetic resonance imaging of the sacroiliac joints in SpA: with or without intravenous contrast media? A preliminary report.

Gentili F, Cantarini L, Fabbroni M, Nigri A, Mazzei FG, Frediani B, Galeazzi M, Volterrani L, Mazzei MA.

Radiol Med. 2019 Nov;124(11):1142-1150. doi: 10.1007/s11547-019-01016-w. Epub 2019 Mar 13.

PMID:
30868439
29.

The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic review.

Bettiol A, Silvestri E, Di Scala G, Amedei A, Becatti M, Fiorillo C, Lopalco G, Salvarani C, Cantarini L, Soriano A, Emmi G.

Rheumatol Int. 2019 Jun;39(6):971-990. doi: 10.1007/s00296-019-04259-y. Epub 2019 Feb 25.

PMID:
30799530
30.

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):301-305. Epub 2019 Jan 18.

31.

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L.

Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.

32.

Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.

Lucherini OM, Vitale A, Orlando I, Sota J, Fabiani C, Franceschini R, Simpatico A, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):110-115. Epub 2018 Dec 12.

PMID:
30582507
33.

Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.

Lopalco G, Venerito V, Sota J, Rigante D, Guerriero S, Orlando I, Franceschini R, Favale R, Lapadula G, Castelli B, Frediani B, Galeazzi M, La Torre F, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):68-73. Epub 2018 Dec 12.

PMID:
30582503
34.

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors.

Barone M, Viggiani MT, Anelli MG, Fanizzi R, Lorusso O, Lopalco G, Cantarini L, Di Leo A, Lapadula G, Iannone F.

J Clin Med. 2018 Dec 1;7(12). pii: E504. doi: 10.3390/jcm7120504.

35.

Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review.

Gaggiano C, Rigante D, Sota J, Grosso S, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):11-17. doi: 10.1007/s10067-018-4361-2. Epub 2018 Nov 28. Review.

PMID:
30488366
36.

An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome.

Federici S, Vanoni F, Ben-Chetrit E, Cantarini L, Frenkel J, Goldbach-Mansky R, Gul A, Hoffman H, Koné-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Martini A, Obici L, Ozen S, Simon A, Hofer M, Ruperto N, Gattorno M; Eurofever and the Pediatric Rheumatology International Trials Organization (PRINTO).

J Rheumatol. 2019 Apr;46(4):429-436. doi: 10.3899/jrheum.180056. Epub 2018 Nov 1.

PMID:
30385706
37.

Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.

Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.

Immunol Lett. 2018 Sep;201:38-44. doi: 10.1016/j.imlet.2018.10.013. Epub 2018 Oct 29.

PMID:
30385329
38.

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.

Lopalco G, Venerito V, Cantarini L, Emmi G, Prisco D, Iannone F.

Intern Emerg Med. 2019 Aug;14(5):719-722. doi: 10.1007/s11739-018-1970-3. Epub 2018 Oct 25. No abstract available.

PMID:
30361849
39.

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Di Scala G, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):267. doi: 10.1007/s10067-018-4302-0.

PMID:
30242638
40.

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2020;28(2):298-304. doi: 10.1080/09273948.2018.1511810. Epub 2018 Aug 27.

PMID:
30148652
41.

Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.

Gentileschi S, Vitale A, Rigante D, Lopalco G, Emmi G, Orlando I, Di Scala G, Sota J, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Iannone F, Cantarini L.

Isr Med Assoc J. 2018 Jul;20(7):438-441.

42.

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

Fabiani C, Vitale A, Rigante D, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Gentileschi S, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Feb;38(2):407-415. doi: 10.1007/s10067-018-4228-6. Epub 2018 Aug 11.

PMID:
30099655
43.

Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.

Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, Lopalco G, Franceschini R, Galeazzi M, Frediani B, Fabiani C, Tosi GM, Cantarini L.

Isr Med Assoc J. 2018 Aug;20(8):517-521.

44.

Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.

Iannone F, Salaffi F, Fornaro M, Di Carlo M, Gentileschi S, Cantarini L, Lopalco G.

Eur J Clin Invest. 2018 Nov;48(11):e13013. doi: 10.1111/eci.13013. Epub 2018 Aug 23.

PMID:
30079593
45.

In silico validation of the Autoinflammatory Disease Damage Index.

Ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler S, Brogan PA, Cantarini L, Cattalini M, Cochino AV, de Benedetti F, Dedeoglu F, de Jesus AA, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Kone-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Özen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Schulert G, Gattorno M, Frenkel J.

Ann Rheum Dis. 2018 Nov;77(11):1599-1605. doi: 10.1136/annrheumdis-2018-213725. Epub 2018 Aug 4.

PMID:
30077992
46.

Clodronate in the management of different musculoskeletal conditions.

Frediani B, Giusti A, Bianchi G, Dalle Carbonare L, Malavolta N, Cantarini L, Saviola G, Molfetta L.

Minerva Med. 2018 Aug;109(4):300-325. doi: 10.23736/S0026-4806.18.05688-4. Review.

47.

Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.

Emmi G, Urban ML, Imazio M, Gattorno M, Maestroni S, Lopalco G, Cantarini L, Prisco D, Brucato A.

Curr Cardiol Rep. 2018 Jun 14;20(8):61. doi: 10.1007/s11886-018-1007-6. Review.

PMID:
29904899
48.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17.

PMID:
29770930
49.

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Oct;37(10):2805-2809. doi: 10.1007/s10067-018-4133-z. Epub 2018 May 15.

PMID:
29766375
50.

The eye involvement in monogenic autoinflammatory diseases: literature review and update.

Sota J, Vitale A, Fabiani C, Frediani B, Rigante D, Tosi GM, Zannin ME, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):44-53. Epub 2018 May 3. Review.

Supplemental Content

Loading ...
Support Center